Home › Funds › M.D. Sass, LLC › DGX

M.D. Sass, LLC position in DGX

QUEST DIAGNOSTICS INC · Health Care

M.D. Sass, LLC reported holding 360,453 shares of DGX (QUEST DIAGNOSTICS INC) in its Q2 2026 13F filing — a position valued at US$76.4M, representing 5.06% of its reported portfolio and ranking #7 among its reported holdings. M.D. Sass, LLC has disclosed DGX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)360.45K sh
Reported value held$76.40M
Portfolio Weight5.06%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How M.D. Sass, LLC's DGX position evolved

M.D. Sass, LLC first disclosed a stake in DGX in Q1 2026 at 299,459 shares (US$58.7M). The position peaked in Q2 2026 at 360,453 shares, worth US$76.4M. Across 2 filings, M.D. Sass, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 360,453 shares valued at US$76.4M — an increase of 60,994 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 299.46K $58.69M New
Q2 2026 360.45K $76.40M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DGX and 13F data

DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 31 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.00B), EdgePoint Investment Group Inc. (US$476.4M), Grantham, Mayo, Van Otterloo & Co. LLC (US$400.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DGX

All DGX fund holders →

FAQ

How long has M.D. Sass, LLC held DGX?

M.D. Sass, LLC has disclosed DGX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is M.D. Sass, LLC's current position in DGX?

As of Q2 2026, M.D. Sass, LLC holds 360.45K shares of DGX (QUEST DIAGNOSTICS INC), valued at $76.40M, representing 5.06% of its reported portfolio and ranking #7.

Has M.D. Sass, LLC been buying or selling DGX?

In the latest 13F filing (Q2 2026), M.D. Sass, LLC increased its position in DGX. The position peaked in Q2 2026 at 360.45K shares.

Which other funds hold DGX?

Other major institutional holders of DGX include Boston Partners, EdgePoint Investment Group Inc., Grantham, Mayo, Van Otterloo & Co. LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.